| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 3976 | 2015 |
| The mutational landscape of lethal castration-resistant prostate cancer CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ... Nature 487 (7406), 239-243, 2012 | 2830 | 2012 |
| The landscape of long noncoding RNAs in the human transcriptome MK Iyer, YS Niknafs, R Malik, U Singhal, A Sahu, Y Hosono, TR Barrette, ... Nature genetics 47 (3), 199-208, 2015 | 2824 | 2015 |
| DNA-repair defects and olaparib in metastatic prostate cancer J Mateo, S Carreira, S Sandhu, S Miranda, H Mossop, R Perez-Lopez, ... New England Journal of Medicine 373 (18), 1697-1708, 2015 | 2398 | 2015 |
| The protein tyrosine kinase family of the human genome DR Robinson, YM Wu, SF Lin Oncogene 19 (49), 5548-5557, 2000 | 1668 | 2000 |
| The landscape of circular RNA in cancer JN Vo, M Cieslik, Y Zhang, S Shukla, L Xiao, Y Zhang, YM Wu, ... Cell 176 (4), 869-881. e13, 2019 | 1396 | 2019 |
| Activating ESR1 mutations in hormone-resistant metastatic breast cancer DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ... Nature genetics 45 (12), 1446-1451, 2013 | 1244 | 2013 |
| Genomic correlates of clinical outcome in advanced prostate cancer W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ... Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019 | 1214 | 2019 |
| Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer IA Asangani, VL Dommeti, X Wang, R Malik, M Cieslik, R Yang, ... Nature 510 (7504), 278-282, 2014 | 1042 | 2014 |
| Integrative clinical genomics of metastatic cancer DR Robinson, YM Wu, RJ Lonigro, P Vats, E Cobain, J Everett, X Cao, ... Nature 548 (7667), 297-303, 2017 | 854 | 2017 |
| The long tail of oncogenic drivers in prostate cancer J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ... Nature genetics 50 (5), 645-651, 2018 | 834 | 2018 |
| Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing DR Robinson, YM Wu, S Kalyana-Sundaram, X Cao, RJ Lonigro, ... Nature genetics 45 (2), 180-185, 2013 | 829 | 2013 |
| Identification of targetable FGFR gene fusions in diverse cancers YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ... Cancer discovery 3 (6), 636-647, 2013 | 810 | 2013 |
| Personalized oncology through integrative high-throughput sequencing: a pilot study S Roychowdhury, MK Iyer, DR Robinson, RJ Lonigro, YM Wu, X Cao, ... Science translational medicine 3 (111), 111ra121-111ra121, 2011 | 684 | 2011 |
| Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer YM Wu, M Cieślik, RJ Lonigro, P Vats, MA Reimers, X Cao, Y Ning, ... Cell 173 (7), 1770-1782. e14, 2018 | 559 | 2018 |
| Integrative clinical sequencing in the management of refractory or relapsed cancer in youth RJ Mody, YM Wu, RJ Lonigro, X Cao, S Roychowdhury, P Vats, KM Frank, ... Jama 314 (9), 913-925, 2015 | 416 | 2015 |
| Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer DR Robinson, S Kalyana-Sundaram, YM Wu, S Shankar, X Cao, B Ateeq, ... Nature medicine 17 (12), 1646-1651, 2011 | 403 | 2011 |
| The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma PW Harms, P Vats, ME Verhaegen, DR Robinson, YM Wu, ... Cancer research 75 (18), 3720-3727, 2015 | 347 | 2015 |
| Expressed pseudogenes in the transcriptional landscape of human cancers S Kalyana-Sundaram, C Kumar-Sinha, S Shankar, DR Robinson, YM Wu, ... Cell 149 (7), 1622-1634, 2012 | 324 | 2012 |
| Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer A Parolia, M Cieslik, SC Chu, L Xiao, T Ouchi, Y Zhang, X Wang, P Vats, ... Nature 571 (7765), 413-418, 2019 | 260 | 2019 |
Dan RobinsonUniversity of MichiganVerified email at umich.edu
